Healthcare Realty Trust reported a small insider purchase this week as Executive Vice President and Chief Financial Officer Daniel Gabbay bought 10 shares of the companys common stock on March 4, 2026. The shares traded at $18.74 apiece, bringing the total value of the disclosed transaction to $187.
Following the trade, Gabbay directly holds 191,158 shares of Healthcare Realty Trust common stock. The filing also notes an indirect holding of 10 shares attributed to a child.
Those ownership details arrive alongside the REITs fourth-quarter 2025 financial report. For the period, Healthcare Realty Trust posted earnings per share of $0.04, ahead of the consensus forecast of $0.002. The companys revenue for the quarter also came in marginally above projections, a combination that the report says prompted a positive market reaction.
Funds from operations - a key metric for real estate investment trusts - were reported at $0.40 per share for the fourth quarter, in line with expectations. The mix of an EPS beat and FFO meeting forecasts presents a nuanced picture of the quarters results.
In response to the quarter, Cantor Fitzgerald raised its price target on Healthcare Realty Trust stock to $21 from $19, while keeping an Overweight rating. The firm cited improvements in the companys processes and personnel, along with enhanced earnings growth potential and a stronger balance sheet, as reasons for the adjustment.
Taken together, the insider filing, quarterly results, and analyst action underscore ongoing changes management and investors are tracking at Healthcare Realty Trust. The insider purchase itself was modest in dollar terms, while the quarter delivered mixed signals - an EPS beat and slightly stronger revenue but FFO that merely met expectations. Cantor Fitzgeralds upgraded target and maintained Overweight stance emphasize the brokers view that structural improvements could support future growth.